Global Isothermal Nucleic Acid Amplification Technology Market Insights Forecasts to 2033

• The Global Isothermal Nucleic Acid Amplification Technology Market Size was Valued at USD 4.2 Billion in 2023
• The Market Size is Growing at a CAGR of 10.4% from 2023 to 2033
• The Worldwide Isothermal Nucleic Acid Amplification Technology Market Size is Expected to Reach USD 11.3 Billion by 2033
• Asia Pacific is Expected to Grow the fastest during the forecast period.

 

Get more details on this report -

Request Free Sample PDF

 

The Global Isothermal Nucleic Acid Amplification Technology Market Size is Anticipated to Exceed USD 11.3 Billion by 2033, Growing at a CAGR of 10.4% from 2023 to 2033.

 

Market Overview

The isothermal nucleic acid application technology (INAAT) is a laboratory technique for quickly amplifying DNA or RNA sequences without temperature cycling, which is required with traditional PCR. As a substitute, it uses a constant temperature and, in so doing, makes the process quicker and more energy-efficient. It is widely applied in medical diagnostics for pathogen identification, including viruses and bacteria. It does not require expensive equipment, unlike PCR, and can be used in resource-constrained environments such as rural clinics or in-field diagnostics. INAAT works by using enzymes that can copy and amplify nucleic acids indefinitely at a constant temperature, allowing for the rapid detection of even trace amounts of genetic material. Tests with INAAT can often be completed in less than an hour. INAAT is an effective tool in the fight against infectious diseases because it produces rapid and accurate results. It has been used in tests for COVID-19, tuberculosis, and other serious infections, making it an essential component of modern diagnostics, particularly when prompt results are required for treatment decisions.

 

Report Coverage

This research report categorizes the market for the global isothermal nucleic acid amplification technology market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global isothermal nucleic acid amplification technology market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global isothermal nucleic acid amplification technology market.

 

Driving Factors

New applications for Isothermal Nucleic Acid Amplification Technology products

New uses of INAAT products are being discovered with the rapid development of existing amplification technologies and the introduction of new ones like SPIA, LAMP, RPA, and SDA. For instance, a report in the Analyst Journal in June 2022 applied LAMP technology in developing a device integrated with a smartphone that can rapidly test the Zika virus from a single blood drop. This development is expected to further increase market penetration in the near future.

 

Restraining Factors

Isothermal nucleic acid amplification technology has some side effects.

The need for instrumentation capable of thermal cycling and temperature control limits the use of point-of-care applications for amplification techniques like PCR. The regulatory environment guiding the development of INAAT-based diagnostics is a significant impediment to industry expansion.

 

Market Segmentation

The global isothermal nucleic acid amplification technology market share is classified into product, technology, and application.

• The reagent segment is expected to hold the largest share of the global isothermal nucleic acid amplification technology market during the forecast period.   

Based on the product, the global isothermal nucleic acid amplification technology market is categorized into instruments and reagents. Among these, the reagent segment is expected to hold the largest share of the global isothermal nucleic acid amplification technology market during the forecast period. Due to their widespread use in hospitals and primary care settings, as well as the growing availability of polymerases with high strand displacement capabilities. Also, with increased market penetration of INAAT diagnostics anticipated in the near future, the adoption of associated reagents is expected to grow at a rapid pace over the forecast period.

 

• The LAMP segment is expected to grow at the fastest CAGR during the forecast period.  

Based on the technology, the global isothermal nucleic acid amplification technology market is categorized into NASBA, HAD, LAMP, SDA, SPIA, NEAR, TMA, RCA, RPA, SMAP2, and others. Among these, the LAMP segment is expected to grow at the fastest CAGR during the forecast period. The technology allows for a variety of detection methods, including real-time fluorescence with intercalators, as well as lateral flow and agarose gel. As a result, the technique is capable of detecting a wide range of RNA and DNA targets in human samples, including Zika virus and SARS-CoV-2. Additionally, demand for the technique is driven by its inhibitor tolerance, which allows it to be used with crude samples and minimally purified nucleic acids.

 

• The infectious disease diagnostics segment is expected to grow at the fastest CAGR during the forecast period. 

Based on the application, the global isothermal nucleic acid amplification technology market is categorized into blood screening, infectious disease diagnostics, cancer, and others. Among these, the infectious disease diagnostics segment is expected to grow at the fastest CAGR during the forecast period. The recent introduction of specific INAAT kits, as well as an increase in the incidence of HIV, hepatitis A and B, and sexually transmitted diseases, are expected to drive segment growth. Also, growing concerns about antimicrobial resistance and a greater emphasis on preventing epidemic outbreaks in developing countries are expected to drive segment growth.

 

Regional Segment Analysis of the Global Isothermal Nucleic Acid Amplification Technology Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

North America is projected to hold the largest share of the global isothermal nucleic acid amplification technology market over the forecast period.

 

Get more details on this report -

Request Free Sample PDF

 

North America is projected to hold the largest share of the global isothermal nucleic acid amplification technology market over the forecast period. Due to the North American region's established research infrastructure and increased demand for nucleic acid amplification-based diagnostics for infectious disease prevention. Additionally, a high per capita healthcare expenditure and an increased emphasis on point-of-care diagnostic methods are expected to drive market expansion.

 

Asia Pacific is expected to grow at the fastest CAGR growth of the global isothermal nucleic acid amplification technology market during the forecast period. The rising prevalence of chronic conditions, increased market player involvement in the region, and rising R&D investments are expected to play a significant role in the Asia Pacific market's growth during the forecast period.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global isothermal nucleic acid amplification technology market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

• Grifols, S.A.
• Hologic, Inc.
• Abbott Laboratories
• Meridian Bioscience
• Eiken Chemical Co., Ltd.
• BioMérieux SA
• Tecan Trading AG
• New England Biolabs
• QIAGEN N.V.
• DiaSorin S.p.A.
• General Electric
• OptiGene Limited
• Quidel Corporation
• Thermo Fisher Scientific
• Genomtec
• Others

 

Key Market Developments

• In February 2023, Sherlock Biosciences announced the acquisition of Sense Biodetection in order to strengthen its position in the INAAT market.

 

• In May 2022, Hologic, Inc. received CE marking for two new molecular assays, Panther Fusion EBV Quant Assay, and Panther Fusion BKV Quant Assay, expanding its transplant pathogen monitoring menu on the Panther Fusion platform.

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global isothermal nucleic acid amplification technology market based on the below-mentioned segments: 

 

Global Isothermal Nucleic Acid Amplification Technology Market, By Product

• Instruments
• Reagent

 

Global Isothermal Nucleic Acid Amplification Technology Market, By Technology

• NASBA
• HAD
• LAMP
• SDA
• SPIA
• NEAR
• TMA
• RCA
• RPA
• SMAP2
• Others

 

Global Isothermal Nucleic Acid Amplification Technology Market, By Application

• Blood Screening
• Infectious Disease Diagnostics
• Cancer
• Others

 

Global Isothermal Nucleic Acid Amplification Technology Market, By Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa